Intended Cooperation
Green Elephant Biotech aims to establish direct collaborations with US-based biotech, pharma, and CGT companies, particularly in preclinical and clinical development phases. The focus lies on pilot projects, technology validation, and long-term adoption of its manufacturing platforms. In addition, the company seeks to build a sustainable pipeline of customers and partners to support long-term growth in the US market, complemented by selective collaborations with research institutions and distribution partners for specific product lines.
Products/Services
Green Elephant Biotech provides advanced cell culture infrastructure designed for scalable and efficient adherent cell manufacturing:
- CellScrew® platform (mini, 6K, 10K) for high-density and space-efficient cell expansion
- Archimedes® One automated adherent bioreactor (in development)
- Bioplastic lab consumables
Green Elephant Biotech is an innovation-driven biotechnology company focused on advancing manufacturing technologies for adherent cell-based therapies.
The company develops scalable and automated solutions that enable more efficient production of Cell & Gene Therapies, vaccines, and biologics. With a strong focus on process efficiency and industrial scalability, Green Elephant Biotech addresses key bottlenecks in modern therapeutic manufacturing.
- Felix Wollenhaupt
- felix@greenebt.com
- https://greenelephantbiotech.com
Arrange an appointment for an
initial consultation
Are you interested in one of our projects? Then book a consultation now. We will be happy to present the project to you.
Philip Okito
General Manager and Co-Founder
- service@traide.de
- + 4922193544511
- Hohenstaufenring 42, 50674 Köln
free of charge & without obligation